From identification of the BTK kinase to effective management of leukemia.

Abstract:

:BTK is a cytoplasmic protein-tyrosine kinase, whose corresponding gene was isolated in the early 1990s. BTK was initially identified by positional cloning of the gene causing X-linked agammaglobulinemia and independently in a search for new kinases. Given the phenotype of affected patients, namely lack of B-lymphocytes and plasma cells with the ensuing inability to mount humoral immune responses, BTK inhibitors were anticipated to have beneficial effects on antibody-mediated pathologies, such as autoimmunity. In contrast to, for example, the SRC-family of cytoplasmic kinases, there was no obvious way in which structural alterations would yield constitutively active forms of BTK, and such mutations were also not found in leukemias or lymphomas. In 2007, the first efficient inhibitor, ibrutinib, was reported and soon became approved both in the United States and in Europe for the treatment of three B-cell malignancies, mantle cell lymphoma, chronic lymphocytic leukemia and Waldenström's macroglobulinemia. Over the past few years, additional inhibitors have been developed, with acalabrutinib being more selective, and recently demonstrating fewer clinical adverse effects. The antitumor mechanism is also not related to mutations in BTK. Instead tumor residency in lymphoid organs is inhibited, making these drugs highly versatile. BTK is one of the only 10 human kinases that carry a cysteine in the adenosine triphosphate-binding cleft. As this allows for covalent, irreversible inhibitor binding, it provides these compounds with a highly advantageous character. This quality may be crucial and bodes well for the future of BTK-modifying medicines, which have been estimated to reach annual multi-billion dollar sales in the future.

journal_name

Oncogene

journal_title

Oncogene

authors

Smith CI

doi

10.1038/onc.2016.343

subject

Has Abstract

pub_date

2017-04-01 00:00:00

pages

2045-2053

issue

15

eissn

0950-9232

issn

1476-5594

pii

onc2016343

journal_volume

36

pub_type

杂志文章,评审

相关文献

ONCOGENE文献大全
  • Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.

    abstract::The C-type lectin domain containing group 14 family members CLEC14A and CD93 are proteins expressed by endothelium and are implicated in tumour angiogenesis. CD248 (alternatively known as endosialin or tumour endothelial marker-1) is also a member of this family and is expressed by tumour-associated fibroblasts and pe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.214

    authors: Khan KA,Naylor AJ,Khan A,Noy PJ,Mambretti M,Lodhia P,Athwal J,Korzystka A,Buckley CD,Willcox BE,Mohammed F,Bicknell R

    更新日期:2017-11-02 00:00:00

  • Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.

    abstract::Expression of polyomavirus middle-T antigen (middle-T) is involved in the formation of various tumors in vivo, e.g. hemangiomas and mammary gland tumors. Several genes have been shown to be activated in middle-T-expressing cells, but the underlying mechanisms have only been partially elucidated. Among the genes regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Besser D,Urich M,Sakaue M,Messerschmitt A,Ballmer-Hofer K,Nagamine Y

    更新日期:1995-12-07 00:00:00

  • Preferential selection of MnSOD transcripts in proliferating normal and cancer cells.

    abstract::Manganese superoxide dismutase (MnSOD) is a nuclear encoded and mitochondrial matrix-localized redox enzyme that is known to regulate the cellular redox environment. Cellular redox environment changes during transitions between quiescent and proliferative cycles. Human MnSOD has two poly(A) sites resulting in two tran...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.325

    authors: Chaudhuri L,Nicholson AM,Kalen AL,Goswami PC

    更新日期:2012-03-08 00:00:00

  • EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.

    abstract::The 120 kD product of the c-cbl oncogene is rapidly tyrosine phosphorylated and recruited to the EGF receptor following ligand binding. Cbl's oncogenic potential is activated by a large carboxy-terminal truncation that generated v-cbl and removes the Ring finger and proline-rich SH3-binding domains. Here we show that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201193

    authors: Thien CB,Langdon WY

    更新日期:1997-05-08 00:00:00

  • Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines.

    abstract::The p21WAF1/CIP1 protein was shown to be a critical downstream effector of p53 and a potent inhibitor of cyclin-dependent kinases. We investigated the effects of exogenous p21WAF1/CIP1 in two different human breast carcinoma (HBC) cell lines MCF-7 and T47D. p21WAF1/CIP1 transfected cells formed significantly reduced n...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sheikh MS,Rochefort H,Garcia M

    更新日期:1995-11-02 00:00:00

  • Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family.

    abstract::We have isolated rat cDNAs that encode two related receptor-like tyrosine kinases. One of these receptors, TIE-1, is the rat homolog of a recently described human receptor-like kinase termed TIE (Partanen et al., 1992). The related TIE-2 receptor has the same organization of amino acid sequence motifs characteristic o...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maisonpierre PC,Goldfarb M,Yancopoulos GD,Gao G

    更新日期:1993-06-01 00:00:00

  • Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.

    abstract::Seventy lung tumors from 53 patients were analysed for alterations of myc family oncogenes, c-myc, N-myc and L-myc, to evaluate when activation of these genes occurs during tumor development. The 53 cases were 17 small cell carcinomas (SCCs), 18 adenocarcinomas, 12 squamous cell carcinomas (SqCs), 4 large cell carcino...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yokota J,Wada M,Yoshida T,Noguchi M,Terasaki T,Shimosato Y,Sugimura T,Terada M

    更新日期:1988-06-01 00:00:00

  • C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences.

    abstract::We have characterized a novel chicken c-myb exon whose sequences are specifically expressed in thymic cells. In situ hybridization experiments indicate that this thymus-specific coding exon is localized on a small chromosome, distinct from the large acrocentric chromosome 3 on which we recently mapped the bulk of 15 e...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Vellard M,Soret J,Viegas-Pequignot E,Galibert F,Nguyen VC,Dutrillaux B,Perbal B

    更新日期:1991-04-01 00:00:00

  • p53 in complex with DNA is resistant to ubiquitin-dependent proteolysis in the presence of HPV-16 E6.

    abstract::The tumour suppressor p53 is a transcription factor with high affinity for specific DNA target sequences. Wild type p53 has a very short half life in normal cells but the protein shows transient accumulation in response to DNA damage, accompanied by up-regulation of target genes such as p21 and induction of growth arr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Molinari M,Milner J

    更新日期:1995-05-04 00:00:00

  • Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay.

    abstract::Many p53 mutants found in human cancer have an altered ability to bind DNA and transactivate gene expression. Re-expression of functional p53 in cells in which the endogenous TP53 gene is inactivated has been demonstrated to restore a non-tumorigenic phenotype. Pharmacological modulation of p53 mutant conformation may...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204428

    authors: Maurici D,Monti P,Campomenosi P,North S,Frebourg T,Fronza G,Hainaut P

    更新日期:2001-06-14 00:00:00

  • Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

    abstract::Resistance to TGF-beta1 occurred in pancreatic cancer cells suggesting that inactivation of TGF-beta inhibitory signaling pathways may play an important role in human pancreatic cancer. The aim of our study was to determine the presence of alterations in the main putative components of the TGF-beta inhibitory signalin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202118

    authors: Villanueva A,García C,Paules AB,Vicente M,Megías M,Reyes G,de Villalonga P,Agell N,Lluís F,Bachs O,Capellá G

    更新日期:1998-10-15 00:00:00

  • Chromosomal imbalances in human lung cancer.

    abstract::A wealth of cytogenetic data has demonstrated that numerous somatic genetic changes are involved in the pathogenesis of human lung cancer. Despite the complexity of the genomic changes observed in these neoplasms, recurrent chromosomal patterns have emerged. In this review, we summarize chromosomal alterations identif...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1205836

    authors: Balsara BR,Testa JR

    更新日期:2002-10-07 00:00:00

  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.

    abstract::Long-lived species Homo sapiens have evolved robust protection mechanisms against cancer by repressing telomerase and maintaining short telomeres, thereby delaying the onset of the majority of cancer types until post-reproductive age. Indeed, telomerase is silent in most differentiated human cells, predominantly due t...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-0872-9

    authors: Yuan X,Larsson C,Xu D

    更新日期:2019-08-01 00:00:00

  • Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.

    abstract::Adult T-cell leukemia/lymphoma (ATL) is an aggressive T-cell neoplasm. While ATL cells in peripheral blood (PB-ATL) are sensitive to anti-CC chemokine receptor 4 treatment, non-PB-ATLs, including lymph node ATLs (LN-ATLs), are more aggressive and resistant. We examined characteristic cytokines and growth factors that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01393-x

    authors: Totani H,Shinjo K,Suzuki M,Katsushima K,Mase S,Masaki A,Ito A,Ri M,Kusumoto S,Komatsu H,Ishida T,Inagaki H,Iida S,Kondo Y

    更新日期:2020-08-01 00:00:00

  • MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.

    abstract::Although cell invasion is a necessary early step in cancer metastasis, its regulation is not well understood. We have previously shown, in human prostate cancer, that transforming growth factor beta (TGFbeta)-mediated increases in cell invasion are dependent upon activation of the serine/threonine kinase, p38 MAP kina...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209337

    authors: Xu L,Chen S,Bergan RC

    更新日期:2006-05-18 00:00:00

  • O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma.

    abstract::The oncogene EWS-FLI1 encodes a chimeric transcription factor expressed in Ewing's sarcoma family tumors (ESFTs). EWS-FLI1 target gene expression is thought to drive ESFT pathogenesis and, therefore, inhibition of EWS-FLI1 activity holds high therapeutic promise. As the activity of many transcription factors is regula...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.484

    authors: Bachmaier R,Aryee DN,Jug G,Kauer M,Kreppel M,Lee KA,Kovar H

    更新日期:2009-03-05 00:00:00

  • Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.

    abstract::MicroRNAs (miRNAs) have important roles in the initiation and progression of human cancer, but their role in head and neck cancer development and progression is not well defined. We aimed to determine whether specific miRNAs and their target mRNAs contribute to head and neck cancer pathogenesis and progression. To ide...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.13

    authors: Nakanishi H,Taccioli C,Palatini J,Fernandez-Cymering C,Cui R,Kim T,Volinia S,Croce CM

    更新日期:2014-02-06 00:00:00

  • CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.

    abstract::14-3-3sigma proteins regulate numerous cellular processes that are important to cancer development. One of its biological roles involves G2 cell-cycle arrest following DNA damage. It has also been reported that the loss of 14-3-3sigma expression via CpG methylation may contribute to malignant transformation by impairi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209462

    authors: Pulukuri SM,Rao JS

    更新日期:2006-08-03 00:00:00

  • c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.

    abstract::Reduced co-expression of the c-fos and c-jun protooncogenes has been correlated with the down regulation of H-2K class I major histocompatibility antigens in high-metastatic cell lines from the Lewis lung carcinoma, B16 melanoma and the K1735 melanoma. Transfection of c-jun and c-fos genes into the high metastatic clo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yamit-Hezi A,Plaksin D,Eisenbach L

    更新日期:1994-04-01 00:00:00

  • Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.

    abstract::Several small GTPases of the Ras superfamily have been shown to antagonize TGFbeta signaling in human tumor cell lines. Some of these GTPases are post-translationally modified by farnesylation, a lipid modification catalyzed by farnesyltransferase and required for the proteins to attach to membranes and to function. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203920

    authors: Adnane J,Bizouarn FA,Chen Z,Ohkanda J,Hamilton AD,Munoz-Antonia T,Sebti SM

    更新日期:2000-11-16 00:00:00

  • NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.

    abstract::The transcription factor nuclear factor kappa B (NF-κB) and the long non-coding RNA (lncRNA) HOTAIR (HOX transcript antisense RNA) have diverse functional roles in cancer. In this study, we show that upregulation of HOTAIR induced platinum resistance in ovarian cancer, and increased HOTAIR levels were observed in recu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.75

    authors: Özeş AR,Miller DF,Özeş ON,Fang F,Liu Y,Matei D,Huang T,Nephew KP

    更新日期:2016-10-13 00:00:00

  • Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.

    abstract::The maintenance cytosine DNA methyltransferase DNMT1 and de novo methyltransferase DNMT3b cooperate to establish aberrant DNA methylation and chromatin complexes to repress gene transcription during cancer development. The expression of DNMT3b was constitutively increased 5-20-fold in hTERT/CDK4-immortalized human bro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.580

    authors: Teneng I,Tellez CS,Picchi MA,Klinge DM,Yingling CM,Snider AM,Liu Y,Belinsky SA

    更新日期:2015-01-29 00:00:00

  • Mimicking the BH3 domain to kill cancer cells.

    abstract::Cancer cells show deviant behavior that induces apoptotic signaling. To survive, cancer cells typically acquire changes enabling evasion of death signals. One way they do this is by increasing the expression of anti-apoptotic BCL-2 proteins. Anti-apoptotic BCL-2 family proteins antagonize death signaling by forming he...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.52

    authors: Ni Chonghaile T,Letai A

    更新日期:2008-12-01 00:00:00

  • hAda3 regulates p14ARF-induced p53 acetylation and senescence.

    abstract::Acetylation is thought to be a key event for p53 activation. We demonstrate that p14ARF-induced senescence of human mammary epithelial cells (MEC) is associated with p53 acetylation and requires hAda3, a component of histone acetyltransferase complexes and a p53 transcriptional coactivator. Expression of the N-termina...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210462

    authors: Sekaric P,Shamanin VA,Luo J,Androphy EJ

    更新日期:2007-09-20 00:00:00

  • Increase in specific DNA binding by carboxyl truncation suggests a mechanism for activation of Myb.

    abstract::Oncogenic forms of the c-myb protein (Myb) often exhibit amino-terminal and/or carboxyl-terminal truncations. When the transcriptional activity of these proteins was examined it was found that carboxyl-truncated Myb is more effective as a transcriptional activator than full-length or amino-truncated Myb. In order to d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ramsay RG,Ishii S,Gonda TJ

    更新日期:1991-10-01 00:00:00

  • Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.

    abstract::Recent evidence has implicated the transmembrane co-receptor neuropilin-1 (NRP1) in cancer progression. Primarily known as a regulator of neuronal guidance and angiogenesis, NRP1 is also expressed in multiple human malignancies, where it promotes tumor angiogenesis. However, non-angiogenic roles of NRP1 in tumor progr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.482

    authors: Tse BWC,Volpert M,Ratther E,Stylianou N,Nouri M,McGowan K,Lehman ML,McPherson SJ,Roshan-Moniri M,Butler MS,Caradec J,Gregory-Evans CY,McGovern J,Das R,Takhar M,Erho N,Alshalafa M,Davicioni E,Schaeffer EM,Jenkins RB

    更新日期:2017-06-15 00:00:00

  • Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.

    abstract::Insights into the pathogenesis of human leukemia have relied heavily on studies of the identified chromosomal translocations found in this group of malignant diseases. Acquired, balanced translocations in acute myelogenous leukemia (AML) generally involve transcriptional regulatory genes, whereas in the myeloprolifera...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1207673

    authors: Nimer SD,Moore MA

    更新日期:2004-05-24 00:00:00

  • PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion.

    abstract::PIKE-A (phosphoinositide 3-kinases (PI 3)-kinase enhancer) is a ubiquitously expressed GTPase, which binds to and enhances protein kinase B (Akt) kinase activity in a guanine nucleotide-dependent manner. PIKE-A is one of the components of the CDK4 amplicon that is amplified in numerous human cancers. However, whether ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210290

    authors: Liu X,Hu Y,Hao C,Rempel SA,Ye K

    更新日期:2007-07-26 00:00:00

  • Downregulation of ceramide synthase-6 during epithelial-to-mesenchymal transition reduces plasma membrane fluidity and cancer cell motility.

    abstract::Epithelial-to-mesenchymal transition (EMT) promotes cell motility, which is important for the metastasis of malignant cells, and blocks CD95-mediated apoptotic signaling triggered by immune cells and chemotherapeutic regimens. CD95L, the cognate ligand of CD95, can be cleaved by metalloproteases and released as a solu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.55

    authors: Edmond V,Dufour F,Poiroux G,Shoji K,Malleter M,Fouqué A,Tauzin S,Rimokh R,Sergent O,Penna A,Dupuy A,Levade T,Theret N,Micheau O,Ségui B,Legembre P

    更新日期:2015-02-19 00:00:00

  • The transcriptional corepressor MTG16a contains a novel nucleolar targeting sequence deranged in t (16; 21)-positive myeloid malignancies.

    abstract::The MTG (Myeloid Translocation Gene) proteins are a family of novel transcriptional corepressors. We report that MTG16a, a protein isoform encoded by the MTG16 gene deranged by the t (16; 21) in myeloid malignancies, is targeted to the nucleolus. The amino acid sequence necessary for nucleolar localization was mapped ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205882

    authors: Hoogeveen AT,Rossetti S,Stoyanova V,Schonkeren J,Fenaroli A,Schiaffonati L,van Unen L,Sacchi N

    更新日期:2002-09-26 00:00:00